Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Avinashnarayan Venkatanarayan
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors
Cancer Cell
Cancer Research
Oncology
Cell Biology
Related publications
RAF Dimer Inhibition Enhances the Antitumor Activity of MEK Inhibitors in K‐RAS Mutant Tumors
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF
Cancer Research
Cancer Research
Oncology
Induction of the Apoptosis Inhibitor ARC by Ras in Human Cancers
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Autoinhibition in Ras Effectors Raf, PI3Kα, and RASSF5: A Comprehensive Review Underscoring the Challenges in Pharmacological Intervention
Biophysical Reviews
Molecular Biology
Structural Biology
Biophysics
REDD1 Loss Reprograms Lipid Metabolism to Drive Progression of RAS Mutant Tumors
Genes and Development
Genetics
Developmental Biology
FOXD3 Is a Mutant B-Raf-Regulated Inhibitor of G1-S Progression in Melanoma Cells
Cancer Research
Cancer Research
Oncology
Differential Interaction of the Ras Family GTP-binding Proteins H-Ras, Rap1A, and R-Ras With the Putative Effector Molecules Raf Kinase and Ral-Guanine Nucleotide Exchange Factor
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
TSC1 Loss Synergizes With KRAS Activation in Lung Cancer Development in the Mouse and Confers Rapamycin Sensitivity
Oncogene
Cancer Research
Genetics
Molecular Biology
SHP2 Inhibition Overcomes RTK-mediated Pathway Re-Activation in KRAS Mutant Tumors Treated With MEK Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology
